|
||||||||
|
|
|
||||||||
|
|
|
WASHINGTON, D.C – President Bush signed the Department of Defense Appropriations Act for Fiscal Year 2008 (H.R. 3222) into law Tuesday morning at his desk in the Oval Office. The legislation included a provision, secured earlier this year by U.S. Rep. Ron Lewis (KY-02), authorizing $2M for the Owensboro Cancer Research Program at the Mitchell Memorial Cancer Center.
“These federal funds will provide the Owensboro Cancer Research Program with new resources to better understand, treat, and prevent cancer,” said Lewis. “This research is critical for the development of important new plant-based pharmaceuticals. The research program’s success could improve the lives of millions across the globe”
The University of Louisville’s Brown Cancer Center and the Owensboro Medical Health System created the Owensboro Cancer Research Program as a joint venture to develop cancer therapies using plant production systems. Research is conducted at laboratories maintained by OMHS at their Mitchell Memorial Cancer Center.
"On behalf of the Owensboro Cancer Research Program, I commend Congressman Lewis and the U.S. House for their support of the biopharmaceutical research currently underway in Owensboro," said Dr. Jeff Barber, Owensboro Medical Health System President and CEO. “This federal funding allows Owensboro Medical Health System to expand the critical research infrastructure needed in developing new lifesaving cancer drugs and treatments.”
The partnership expands Owensboro’s position as a leader in plant-based pharmaceutical research, which already includes the industry leader, Kentucky Bioprocessing LLC.
###
|
 |
Press Release List |  |